Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 51
Filter
1.
Rev. clín. esp. (Ed. impr.) ; 224(3): 123-132, mar. 2024. tab, graf
Article in Spanish | IBECS | ID: ibc-231452

ABSTRACT

Propósito Analizar el impacto de la enfermedad pulmonar obstructiva crónica (EPOC) y el asma bronquial sobre el manejo terapéutico y el pronóstico de los pacientes con insuficiencia cardiaca (IC). Métodos Análisis de la información contenida en un registro clínico de pacientes remitidos a una unidad especializada de IC entre enero de 2010 y junio de 2022. Se compararon su perfil clínico, el tratamiento y el pronóstico en base a la presencia de EPOC o asma bronquial. El análisis de supervivencia se realizó mediante los métodos de Kaplan-Meier y Cox. La mediana de seguimiento fue de 1.493 días. Resultados Se estudiaron 2.577 pacientes, de los cuales 251 (9,7%) presentaban EPOC y 96 (3,7%), asma bronquial. Observamos diferencias significativas entre los tres grupos con respecto a la prescripción de betabloqueantes (EPOC=89,6%; asma=87,5%; no broncopatía=94,1%; p=0,002) e inhibidores del cotransportador de sodio-glucosa tipo2 (EPOC=35,1%; asma=50%; no broncopatía=38,3%; p=0,036). Además, los pacientes con patología bronquial recibieron con menor frecuencia un desfibrilador (EPOC=20,3%; asma=20,8%; no broncopatía=29%; p=0,004). La presencia de EPOC se asoció de forma independiente con mayor riesgo de muerte por cualquier causa (HR=1,64; IC95%: 1,33-2,02), muerte u hospitalización por IC (HR=1,47; IC95%: 1,22-1,76) y muerte cardiovascular o trasplante cardiaco (HR=1,39; IC95%: 1,08-1,79) en comparación con la ausencia de broncopatía. La presencia de asma bronquial no se asoció a un impacto significativo sobre los desenlaces analizados. Conclusiones La EPOC, pero no el asma bronquial, es un factor pronóstico adverso e independiente en pacientes con IC. (AU)


Purpose To analyze the impact of chronic obstructive pulmonary disease (COPD) and bronchial asthma on therapeutic management and prognosis of patients with heart failure (HF). Methods Analysis of the information collected in a clinical registry of patients referred to a specialized HF unit from January-2010 to June-2012. Clinical profile, treatment and prognosis of patients was evaluated, according to the presence of COPD or asthma. Survival analyses were conducted by means of Kaplan-Meier and Cox's methods. Median follow-up was 1493 days. Results We studied 2577 patients, of which 251 (9.7%) presented COPD and 96 (3.7%) bronchial asthma. Significant differences among study groups were observed regarding to the prescription of beta-blockers (COPD=89.6%; asthma=87.5%; no bronchopathy=94.1%; P=.002) and SGLT2 inhibitors (COPD=35.1%; asthma=50%; no bronchopathy=38.3%; P=.036). Also, patients with bronchial disease received less frequently a defibrillator (COPD=20.3%; asthma=20.8%; no broncopathy=29%; P=.004). COPD was independently associated with increased risk of all-cause mortality (HR=1.64; 95%CI: 1.33-2.02), all-cause death or HF admission (HR=1.47; 95%CI: 1.22-1.76) and cardiovascular death or heart transplantation (HR=1.39; 95%CI: 1.08-1.79) as compared with patients with no bronchopathy. Bronchial asthma was not significantly associated with increased risk of adverse outcomes. Conclusions COPD, but not asthma, is an adverse independent prognostic factor in patients with HF. (AU)


Subject(s)
Humans , Heart Failure , Asthma/drug therapy , Asthma/therapy , Pulmonary Disease, Chronic Obstructive/drug therapy , Pulmonary Disease, Chronic Obstructive/therapy , Prognosis , Retrospective Studies
2.
Rev Clin Esp (Barc) ; 224(3): 123-132, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38325624

ABSTRACT

PURPOSE: To analyze the impact of chronic obstructive pulmonary disease (COPD) and bronchial asthma on therapeutic management and prognosis of patients with heart failure (HF). METHODS: Analysis of the information collected in a clinical registry of patients referred to a specialized HF unit from January-2010 to June-2012. Clinical profile, treatment and prognosis of patients was evaluated, according to the presence of COPD or asthma. Survival analyses were conducted by means of Kaplan-Meier and Cox's methods. Median follow-up was 1493 days. RESULTS: We studied 2577 patients, of which 251 (9.7%) presented COPD and 96 (3.7%) bronchial asthma. Significant differences among study groups were observed regarding to the prescription of beta-blockers (COPD=89.6%; asthma=87.5%; no bronchopathy=94.1%; p=0.002) and SGLT2 inhibitors (COPD=35.1%; asthma=50%; no bronchopathy=38.3%; p=0.036). Also, patients with bronchial disease received less frequently a defibrillator (COPD=20.3%; asthma=20.8%; no broncopathy=29%; p=0.004). COPD was independently associated with increased risk of all-cause mortality (HR=1.64; 95% CI 1.33-2.02), all-cause death or HF admission (HR=1.47; 95% CI 1.22-1.76) and cardiovascular death or heart transplantation (HR=1.39; 95% CI 1.08-1.79) as compared with patients with no bronchopathy. Bronchial asthma was not significantly associated with increased risk of adverse outcomes. CONCLUSIONS: COPD, but not asthma, is an adverse independent prognostic factor in patients with HF.


Subject(s)
Asthma , Heart Failure , Pulmonary Disease, Chronic Obstructive , Humans , Prognosis , Proportional Hazards Models , Pulmonary Disease, Chronic Obstructive/complications , Pulmonary Disease, Chronic Obstructive/epidemiology , Pulmonary Disease, Chronic Obstructive/drug therapy , Asthma/complications , Asthma/epidemiology , Heart Failure/complications , Heart Failure/epidemiology , Heart Failure/therapy
3.
Ann R Coll Surg Engl ; 105(S2): S69-S74, 2023 Aug.
Article in English | MEDLINE | ID: mdl-36927165

ABSTRACT

Since the start of the pandemic, over 400 million COVID-19 swab tests have been conducted in the UK with a non-trivial number associated with skull base injury. Given the continuing use of nasopharyngeal swabs, further cases of swab-associated skull base injury are anticipated. We describe a 54-year-old woman presenting with persistent colourless nasal discharge for 2 weeks following a traumatic COVID-19 nasopharyngeal swab. A ß2-transferrin test confirmed cerebrospinal fluid (CSF) rhinorrhoea and a high-resolution sinus computed tomography (CT) scan demonstrated a cribriform plate defect. Magnetic resonance imaging showed radiological features of idiopathic intracranial hypertension (IIH): a Yuh grade V empty sella and thinned anterior skull base. Twenty-four hour intracranial pressure (ICP) monitoring confirmed raised pressures, prompting insertion of a ventriculoperitoneal shunt. The patient underwent CT cisternography and endoscopic transnasal repair of the skull base defect using a fluorescein adjuvant, without complications. A systematic search was performed to identify cases of COVID-19 swab-related injury. Eight cases were obtained, of which three presented with a history of IIH. Two cases were complicated by meningitis and were managed conservatively, whereas six required endoscopic skull base repair and one had a ventriculoperitoneal shunt inserted. A low threshold for high-resolution CT scanning is suggested for patients presenting with rhinorrhoea following a nasopharyngeal swab. The literature review suggests an underlying association between IIH, CSF rhinorrhoea and swab-related skull base injury. We highlight a comprehensive management pathway for these patients, including high-resolution CT with cisternography, ICP monitoring, shunt and fluorescein-based endoscopic repair to achieve the best standard of care.


Subject(s)
COVID-19 , Cerebrospinal Fluid Rhinorrhea , Fractures, Bone , Pseudotumor Cerebri , Female , Humans , Middle Aged , COVID-19/complications , Cerebrospinal Fluid Rhinorrhea/etiology , Skull Base , Pseudotumor Cerebri/complications , Fractures, Bone/complications , Nasopharynx/diagnostic imaging , Fluoresceins
4.
Clin Radiol ; 77(10): e758-e764, 2022 10.
Article in English | MEDLINE | ID: mdl-35850868

ABSTRACT

AIM: To develop and test a model based on a convolutional neural network that can identify enteric tube position accurately on chest radiography. MATERIALS AND METHODS: The chest radiographs of adult patients were classified by radiologists based on enteric tube position as either critically misplaced (within the respiratory tract) or not critically misplaced (misplaced within the oesophagus or safely positioned below the diaphragm). A deep-learning model based on the 121-layer DenseNet architecture was developed using a training and validation set of 4,693 chest radiographs. The model was evaluated on an external test data set from a separate institution that consisted of 1,514 consecutive radiographs with a real-world incidence of critically misplaced enteric tubes. RESULTS: The receiver operator characteristic area under the curve was 0.90 and 0.92 for the internal validation and external test data sets, respectively. For the external data set with a prevalence of 4.4% of critically misplaced enteric tubes, the model achieved high accuracy (92%), sensitivity (80%), and specificity (92%) for identifying a critically misplaced enteric tube. The negative predictive value (99%) was higher than the positive predictive value (32%). CONCLUSION: The present study describes the development and external testing of a model that accurately identifies an enteric tube misplaced within the respiratory tract. This model could help reduce the risk of the catastrophic consequences of feeding through a misplaced enteric tube.


Subject(s)
Deep Learning , Adult , Humans , Neural Networks, Computer , Radiography , Radiography, Thoracic , Respiratory System , Retrospective Studies
5.
Rev Clin Esp (Barc) ; 222(3): 152-160, 2022 Mar.
Article in English | MEDLINE | ID: mdl-35227424

ABSTRACT

BACKGROUND AND OBJECTIVE: Patients with heart failure are classified into three phenotypes based on left ventricular ejection fraction. This work aimed to compare the clinical profile, treatment, prognosis, and causes of death of patients with heart failure and reduced (<40%, HF-rEF), preserved (≥50%, HF-pEF), or mid-range (40-49%, HF-mrEF) left ventricular ejection fraction. METHODS: An analysis was conducted on the clinical data included in a prospective registry of patients with heart failure who were referred to a specific Cardiology unit from 2010 to 2019. RESULTS: A total of 1404 patients with HF-rEF, 239 patients with HF-mrEF, and 266 patients with HF-pEF were analyzed. Significant differences were observed among the groups in regard to several clinical characteristics and the frequency of prescription of neurohormonal blocking drugs. A multivariate Cox regression revealed an increased risk of all-cause mortality in patients with HF-pEF (hazard ratio 1.36; 95% confidence interval 1.03-1.80; p = 0.028) and patients with HF-mrEF (hazard ratio 1.36; 95% confidence interval 1.03-1.78; p = 0.029) as compared to patients with HF-rEF. Heart failure was the most frequent cause of death in the three subgroups. A higher relative weight of sudden death as a cause of death was observed among patients with HF-rEF while the relative weight of non-cardiovascular causes of death was higher among patients with HF-pEF and HF-mrEF. CONCLUSIONS: This study confirms the existence of significant differences among patients with HF-rEF, HF-mrEF, and HF-pEF with regard to their clinical profile, therapeutic management, prognosis, and causes of death.


Subject(s)
Cardiology , Heart Failure , Cause of Death , Humans , Prognosis , Stroke Volume , Ventricular Function, Left
6.
Rev. clín. esp. (Ed. impr.) ; 222(3): 152-160, mar. 2022. tab, graf
Article in Spanish | IBECS | ID: ibc-204635

ABSTRACT

Antecedente y objetivo: Los pacientes con insuficiencia cardíaca se caracterizan en 3 fenotipos en función de su fracción de eyección ventricular izquierda. El propósito de este estudio fue comparar el perfil clínico, el tratamiento, el pronóstico y las causas de muerte de los pacientes con insuficiencia cardíaca y fracción de eyección ventricular izquierda reducida (<40%, IC-FEr), preservada (≥50%, IC-FEp) o en rango medio (40-49%, IC-FErm). Metodología: Análisis de la información clínica recogida en un registro prospectivo de pacientes con insuficiencia cardíaca remitidos a una consulta monográfica de Cardiología entre 2010 y 2019. Resultados: Se estudiaron 1.404 pacientes con IC-FEr, 239 pacientes con IC-FErm y 266 pacientes con IC-FEp. Se observaron diferencias significativas entre los 3 grupos en relación con diversas características clínicas, y en cuanto a la tasa de prescripción de fármacos moduladores de la respuesta neurohormonal. La regresión de Cox multivariante reveló un incremento del riesgo de muerte por cualquier causa en los pacientes con IC-FEp (hazard-ratio 1,36; intervalo de confianza al 95% 1,03-1,80; p=0,028) e IC-FErm (hazard-ratio 1,36; intervalo de confianza al 95% 1,03-1,78; p=0,029) en comparación con los pacientes con IC-FEr. La insuficiencia cardíaca fue la causa más frecuente de muerte en los 3 grupos; se observó un mayor peso relativo de la muerte súbita en los pacientes con IC-FEr, mientras que las causas no cardiovasculares de muerte tuvieron un peso relativo mayor en los pacientes con IC-FEp e IC-FErm. Conclusiones: El estudio confirma la existencia de diferencias significativas en el perfil clínico, manejo terapéutico, pronóstico y causas de muerte de los pacientes con IC-FEr, IC-FErm e IC-FEp (AU)


Background and objective: Patients with heart failure are classified into three phenotypes based on left ventricular ejection fraction. This work aimed to compare the clinical profile, treatment, prognosis, and causes of death of patients with heart failure and reduced (<40%, HF-rEF), preserved (≥50%, HF-pEF), or mid-range (40–49%, HF-mrEF) left ventricular ejection fraction. Methods: An analysis was conducted on the clinical data included in a prospective registry of patients with heart failure who were referred to a specific Cardiology unit from 2010 to 2019. Results: A total of 1,404 patients with HF-rEF, 239 patients with HF-mrEF, and 266 patients with HF-pEF were analyzed. Significant differences were observed among the groups in regard to several clinical characteristics and the frequency of prescription of neurohormonal blocking drugs. A multivariate Cox regression revealed an increased risk of all-cause mortality in patients with HF-pEF (hazard ratio 1.36; 95% confidence interval 1.03-1.80; p=0.028) and patients with HF-mrEF (hazard ratio 1.36; 95% confidence interval 1.03–1.78; p=0.029) as compared to patients with HF-rEF. Heart failure was the most frequent cause of death in the three subgroups. A higher relative weight of sudden death as a cause of death was observed among patients with HF-rEF while the relative weight of non-cardiovascular causes of death was higher among patients with HF-pEF and HF-mrEF. Conclusions: This study confirms the existence of significant differences among patients with HF-rEF, HF-mrEF, and HF-pEF with regard to their clinical profile, therapeutic management, prognosis, and causes of death (AU)


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Heart Failure/mortality , Heart Failure/physiopathology , Cause of Death , Stroke Volume/physiology , Ventricular Dysfunction, Left/physiopathology
9.
Am J Transplant ; 16(7): 2139-47, 2016 07.
Article in English | MEDLINE | ID: mdl-26755448

ABSTRACT

We have assessed whether HLA immunogenicity as defined by differences in donor-recipient HLA amino-acid sequence (amino-acid mismatch score, AMS; and eplet mismatch score, EpMS) and physicochemical properties (electrostatic mismatch score, EMS) enables prediction of allosensitization to HLA, and also prediction of the risk of an individual donor-recipient HLA mismatch to induce donor-specific antibody (DSA). HLA antibody screening was undertaken using single-antigen beads in 131 kidney transplant recipients returning to the transplant waiting list following first graft failure. The effect of AMS, EpMS, and EMS on the development of allosensitization (calculated reaction frequency [cRF]) and DSA was determined. Multivariate analyses, adjusting for time on the waiting list, maintenance on immunosuppression after transplant failure, and graft nephrectomy, showed that AMS (odds ratio [OR]: 1.44 per 10 units, 95% CI: 1.02-2.10, p = 0.04) and EMS (OR: 1.27 per 10 units, 95% CI: 1.02-1.62, p = 0.04) were independently associated with the risk of developing sensitization to HLA (cRF > 15%). AMS, EpMS, and EMS were independently associated with the development of HLA-DR and HLA-DQ DSA, but only EMS correlated with the risk of HLA-A and -B DSA development. Differences in donor-recipient HLA amino-acid sequence and physicochemical properties enable better assessment of the risk of HLA-specific sensitization than conventional HLA matching.


Subject(s)
Graft Rejection/diagnosis , HLA-DQ Antigens/immunology , HLA-DR Antigens/immunology , Isoantibodies/immunology , Kidney Failure, Chronic/surgery , Kidney Transplantation/adverse effects , Tissue Donors , Adult , Female , Glomerular Filtration Rate , Graft Rejection/etiology , Graft Survival , Histocompatibility Testing , Humans , Kidney Function Tests , Male , Prognosis , Risk Factors , Transplant Recipients
11.
Am J Transplant ; 15(11): 2931-9, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26108421

ABSTRACT

Most kidneys from potential elderly circulatory death (DCD) donors are declined. We report single center outcomes for kidneys transplanted from DCD donors over 70 years old, using preimplantation biopsy Remuzzi grading to inform implantation as single or dual transplants. Between 2009 and 2012, 43 single transplants and 12 dual transplants were performed from elderly DCD donors. Remuzzi scores were higher for dual than single implants (4.4 vs. 3.4, p < 0.001), indicating more severe baseline injury. Donor and recipient characteristics for both groups were otherwise similar. Early graft loss from renal vein thrombosis occurred in two singly implanted kidneys, and in one dual-implanted kidney; its pair continued to function satisfactorily. Death-censored graft survival at 3 years was comparable for the two groups (single 94%; dual 100%), as was 1 year eGFR. Delayed graft function occurred less frequently in the dual-implant group (25% vs. 65%, p = 0.010). Using this approach, we performed proportionally more kidney transplants from elderly DCD donors (23.4%) than the rest of the United Kingdom (7.3%, p < 0.001), with graft outcomes comparable to those achieved nationally for all deceased-donor kidney transplants. Preimplantation biopsy analysis is associated with acceptable transplant outcomes for elderly DCD kidneys and may increase transplant numbers from an underutilized donor pool.


Subject(s)
Cardiovascular Diseases/mortality , Delayed Graft Function/epidemiology , Kidney Transplantation/methods , Tissue Donors/statistics & numerical data , Tissue and Organ Procurement/methods , Age Factors , Aged , Biopsy, Needle , Cohort Studies , Delayed Graft Function/pathology , Female , Graft Rejection/epidemiology , Graft Survival , Humans , Immunohistochemistry , Intraoperative Care/methods , Kaplan-Meier Estimate , Kidney Transplantation/adverse effects , Male , Prognosis , Registries , Retrospective Studies , Statistics, Nonparametric , Survival Rate , Transplant Recipients/statistics & numerical data , Treatment Outcome , United Kingdom
12.
Am J Transplant ; 15(9): 2475-82, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25989187

ABSTRACT

A significant number of pancreases procured for transplantation are deemed unsuitable due to concerns about graft quality and the associated risk of complications. However, this decision is subjective and some declined grafts may be suitable for transplantation. Ex vivo normothermic perfusion (EVNP) prior to transplantation may allow a more objective assessment of graft quality and reduce discard rates. We report ex vivo normothermic perfusion of human pancreases procured but declined for transplantation, with ABO-compatible warm oxygenated packed red blood cells for 1-2 h. Five declined human pancreases were assessed using this technique after a median cold ischemia time of 13 h 19 min. One pancreas, with cold ischemia over 30 h, did not appear viable and was excluded. In the remaining pancreases, blood flow and pH were maintained throughout perfusion. Insulin secretion was observed in all four pancreases, but was lowest in an older donation after cardiac death pancreas. Amylase levels were highest in a gland with significant fat infiltration. This is the first study to assess the perfusion, injury, as measured by amylase, and exocrine function of human pancreases using EVNP and demonstrates the feasibility of the approach, although further refinements are required.


Subject(s)
Clinical Decision-Making , Delayed Graft Function/prevention & control , Donor Selection , Organ Preservation , Pancreas Transplantation , Perfusion/methods , Tissue and Organ Harvesting , Adolescent , Adult , Amylases/metabolism , Delayed Graft Function/diagnosis , Delayed Graft Function/metabolism , Female , Follow-Up Studies , Graft Survival , Humans , Male , Middle Aged , Outcome Assessment, Health Care , Temperature
14.
Bone Marrow Transplant ; 50(4): 540-4, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25621806

ABSTRACT

We determined whether assessment of the immunogenicity of individual donor-recipient HLA mismatches based on differences in their amino-acid sequence and physiochemical properties predicts clinical outcome following haematopoietic SCT (HSCT). We examined patients transplanted with 9/10 single HLA class I-mismatched grafts (n=171) and 10/10 HLA-A-, -B-, -C-, -DRB1- and -DQB1-matched grafts (n=168). A computer algorithm was used to determine the physiochemical disparity (electrostatic mismatch score (EMS) and hydrophobic mismatch score (HMS)) of mismatched HLA class I specificities in the graft-versus-host direction. Patients transplanted with HLA-mismatched grafts with high EMS/HMS had increased incidence of ⩾grade II acute GVHD (aGVHD) compared with patients transplanted with low EMS/HMS grafts; patients transplanted with low and medium EMS/HMS grafts had similar incidence of aGVHD to patients transplanted with 10/10 HLA-matched grafts. Mortality was higher following single HLA-mismatched HSCT but was not correlated with HLA physiochemical disparity. Assessment of donor-recipient HLA incompatibility based on physiochemical HLA disparity may enable better selection of HLA-mismatched donors in HSCT.


Subject(s)
Databases, Factual , Graft vs Host Disease , HLA Antigens , Hematopoietic Stem Cell Transplantation , Unrelated Donors , Adolescent , Adult , Algorithms , Allografts , Child , Female , Graft vs Host Disease/etiology , Graft vs Host Disease/immunology , Graft vs Host Disease/mortality , HLA Antigens/chemistry , HLA Antigens/genetics , HLA Antigens/immunology , Humans , Incidence , Male , Netherlands , Risk Factors
15.
Angiología ; 66(5): 241-245, sept.-oct. 2014. tab
Article in Spanish | IBECS | ID: ibc-128224

ABSTRACT

INTRODUCCIÓN: El objetivo de este estudio es evaluar la validez de la cartografía arterial con ecodoppler respecto a la arteriografía para la detección de lesiones significativas y la planificación preoperatoria en los pacientes con enfermedad arterial periférica (EAP). MATERIALES Y MÉTODOS: Estudio transversal de validación de prueba diagnóstica, incluyendo pacientes consecutivos intervenidos de EAP en nuestro centro. Se registraron variables basales, clínicas y factores de riesgo. Se analizaron los ejes ilio-femoropoplíteos, valorando los parámetros ecográficos de la lesión (estenosis < 50%; 50-69%; ≥ 70% y oclusión) así como la planificación quirúrgica propuesta (endovascular, cirugía abierta o cirugía combinada) comparándolos con los hallazgos arteriográficos, sin valorar los vasos distales. RESULTADOS: Desde enero del 2012 hasta diciembre del 2013 se incluyeron 145 extremidades inferiores de 143 pacientes. El grado de concordancia kappa en la detección de estenosis significativas y oclusiones fue mayor que 0,85 en el sector ilíaco, de uno en el sector femoral y 0,98 en el sector poplíteo. El grado de concordancia kappa entre el procedimiento indicado en función de la cartografía y el que finalmente se realizó fue 0,75. CONCLUSIONES: Nuestra experiencia muestra que la cartografía arterial con ecodoppler es una técnica válida para la planificación preoperatoria en los pacientes con EAP, presentando mayor grado de concordancia en el segmento femoropoplíteo


INTRODUCTION: The objective of this study is to evaluate the validity of the doppler arterial mapping compared to angiography for the detection of significant lesions, and preoperative planning in patients with peripheral artery disease (PAD).MATERIALS AND METHODS: Cross-validation study of diagnostic test, including consecutive patients with PAD who were treated in our institution. Baseline clinical variables and risk factors were recorded. The ilio-femoro-popliteal axis were analyzed, assessing the ultrasound parameters of the lesion (stenosis <50%, 50-69%,≥70%, or occlusion) and the proposed surgical planning(endovascular, open surgery, or combined surgery) compared with angiographic findings without evaluating the distal vessels. RESULTS: A total of 145 lower limbs of 143 patients were included from January 2012 to December 013. Kappa agreement in the detection of significant stenosis and occlusions was increased to 0.85 in the iliac sector, 1.0 in the femoral sector, and 0.98 in the popliteal sector. The closeness of agreement between the kappa procedure based on mapping and that finally performed was 0.75. CONCLUSIONS: Our experience shows that the arterial mapping with doppler color ultrasound is valid for preoperative planning in patients with PAD, showing a greater degree of consistenc yin the femoro-popliteal segment


Subject(s)
Humans , Male , Female , Angiography , Peripheral Arterial Disease/pathology , Peripheral Arterial Disease/surgery , Peripheral Arterial Disease/therapy , Constriction, Pathologic/pathology , Constriction, Pathologic/surgery , Lower Extremity/pathology , Femoral Artery/pathology , Surgical Procedures, Operative/trends , Surgical Procedures, Operative
16.
Conserv Biol ; 28(4): 1109-18, 2014 Aug.
Article in English | MEDLINE | ID: mdl-25187922

ABSTRACT

Assessing temporal changes in species extinction risk is necessary for measuring conservation success or failure and for directing conservation resources toward species or regions that would benefit most. Yet, there is no long-term picture of genuine change that allows one to associate species extinction risk trends with drivers of change or conservation actions. Through a review of 40 years of IUCN-related literature sources on species conservation status (e.g., action plans, red-data books), we assigned retrospective red-list categories to the world's carnivores and ungulates (2 groups with relatively long generation times) to examine how their extinction risk has changed since the 1970s. We then aggregated species' categories to calculate a global trend in their extinction risk over time. A decline in the conservation status of carnivores and ungulates was underway 40 years ago and has since accelerated. One quarter of all species (n = 498) moved one or more categories closer to extinction globally, while almost half of the species moved closer to extinction in Southeast Asia. The conservation status of some species improved (toward less threatened categories), but for each species that improved in status 8 deteriorated. The status of large-bodied species, particularly those above 100 kg (including many iconic taxa), deteriorated significantly more than small-bodied species (below 10 kg). The trends we found are likely related to geopolitical events (such as the collapse of Soviet Union), international regulations (such as CITES), shifting cultural values, and natural resource exploitation (e.g., in Southeast Asia). Retrospective assessments of global species extinction risk reduce the risk of a shifting baseline syndrome, which can affect decisions on the desirable conservation status of species. Such assessments can help conservationists identify which conservation policies and strategies are or are not helping safeguard biodiversity and thus can improve future strategies.


Subject(s)
Carnivora/physiology , Conservation of Natural Resources , Endangered Species , Mammals/physiology , Animals , Biodiversity , Population Density , Risk Assessment
17.
Eur Heart J Acute Cardiovasc Care ; 2(1): 19-26, 2013 Mar.
Article in English | MEDLINE | ID: mdl-24062930

ABSTRACT

AIMS: To compare the performance of the CRUSADE, ACUITY-HORIZONS, and ACTION risk models in the ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI). METHODS: We studied all consecutive patients with STEMI who underwent PPCI at our institution between 2006 and 2010 (n=1391). The CRUSADE, ACUITY-HORIZONS, and ACTION risk scores were calculated based on the patients' clinical characteristics. The occurrence of in-hospital major bleeding (defined as the composite of intracranial or intraocular bleeding, access site haemorrhage requiring intervention, reduction in haemoglobin ≥4 g/dl without or ≥3g/dl with overt bleeding source, reoperation for bleeding, or blood transfusion) reached 9.8%. Calibration and discrimination of the three risk models were evaluated by the Hosmer-Lemeshow test and the C-statistic, respectively. We compared the predictive accuracy of the risk scores by the DeLong non-parametric test. RESULTS: Calibration of the three risk scores was adequate, given the non-significant results of Hosmer-Lemeshow test for the three risk models. Discrimination of CRUSADE, ACUITY-HORIZONS, and ACTION models was good (C-statistic 0.77, 0.70, and 0.78, respectively). The CRUSADE and ACTION risk scores had a greater predictive accuracy than the ACUITY-HORIZONS risk model (z=3.89, p-value=0.0001 and z=3.51, p-value=0.0004, respectively). There was no significant difference between the CRUSADE and ACTION models (z=0.63, p=0.531). CONCLUSIONS: The CRUSADE, ACUITY-HORIZONS, and ACTION scores are useful tools for the risk stratification of bleeding in STEMI treated by PPCI. Our findings favour the CRUSADE and ACTION risk models over the ACUITY-HORIZONS risk score.

18.
Ann R Coll Surg Engl ; 95(4): 258-62, 2013 May.
Article in English | MEDLINE | ID: mdl-23676809

ABSTRACT

INTRODUCTION: Fine needle aspiration (FNA) is a safe and quick method of diagnosing superficial lumps, which aids preoperative planning. However, FNA of the parotid gland has not gained the widespread acceptance noted in other head and neck lumps. The aim of this study was to determine the ability of FNA of the parotid gland to differentiate benign and malignant disease, and to determine the impact on surgical outcome. METHODS: A retrospective analysis of 201 consecutive parotid operations with preoperative FNA in a large district hospital in the UK was performed. The diagnostic characteristics were calculated for benign and malignant disease, and the impact on surgical procedure was determined. RESULTS: In identifying benign disease, FNA has a sensitivity of 85% and a specificity of 76%. In detecting malignant disease, FNA has a sensitivity and specificity of 52% and 92% respectively. A false positive on FNA was associated with a higher incidence of neck dissection. CONCLUSIONS: FNA is a useful diagnostic test. However, owing to low sensitivity, it is necessary to interpret it in the context of all other clinical information.


Subject(s)
Biopsy, Fine-Needle , Parotid Gland/pathology , Parotid Neoplasms/pathology , Biopsy, Fine-Needle/standards , Endoscopic Ultrasound-Guided Fine Needle Aspiration/standards , Humans , Image-Guided Biopsy/standards , Magnetic Resonance Imaging , Parotid Gland/surgery , Parotid Neoplasms/surgery , Preoperative Care/methods , Retrospective Studies , Sensitivity and Specificity , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...